Andrew Abraham MD Net Worth: How Estimates Are Derived

The most financially significant Andrew Abraham, MD in public records is the founder and CEO of Orgain Inc., a nutrition brand that reached roughly $1 billion in annual revenue and was valued at over $2 billion when Nestlé Health Science acquired a majority stake in early 2022. Based on that transaction and subsequent valuation signals, a reasonable estimated net worth range for Andrew Abraham (the Orgain founder) sits between $200 million and $600 million, with the wide spread reflecting unknown equity dilution, retained stake size, and private deal terms. If you are researching a different Andrew Abraham, MD, such as the family medicine physician practicing in Long Beach, CA (NPI 1740526482), the financial profile is entirely different and far more modest, as discussed below.

First, confirm which Andrew Abraham, MD you mean

This is genuinely important because at least three distinct public figures named Andrew Abraham (or Andrew Abraham, MD) appear in searchable records, and conflating them is easy to do. The three most likely candidates a researcher encounters are:

• Andrew Abraham, MD (Orgain founder): A physician who left clinical medicine to build Orgain Inc., an organic nutrition and protein shake company headquartered in Orange County, CA. He is listed in the Orange County Business Journal's OC50 2025 as Founder and CEO of Orgain. This is the individual behind any large net-worth figure you will find attached to the name.
• Andrew Abraham, MD (Long Beach family medicine): A family medicine physician associated with Cal-Care Medical Group / Priority Care Medical Group at 500 W Willow St, Long Beach, CA 90806. His NPI is 1740526482, registered since December 28, 2012. This person's wealth profile resembles that of a typical employed or small-group primary care physician.
• Andrew Abraham (non-physician): Public records also surface an Andrew Abraham in Phoenix lobbyist registrations, a Montana small business owner context, and a bankruptcy court filing, none of which relate to either physician above.

The fastest way to confirm which individual a source is discussing is to check whether Orgain or any nutrition business is mentioned alongside the name. If the source says nothing about Orgain, you may be looking at the Long Beach clinician or a completely unrelated person. The NPI registry (searchable at nppes.cms.hhs.gov) is the most reliable anchor for identifying any U.S. physician by name, state, and specialty.

Estimated net worth range and why it varies

For Andrew Abraham, MD the Orgain founder, the $200M to $600M range is built on the Nestlé Health Science deal. Nestlé acquired a 51% majority stake in Orgain in February 2022 at a reported valuation above $2 billion, and OCBJ later reported that valuation climbed to over $3 billion. If Abraham held, say, 30 to 40 percent of equity before any dilution at the time of the transaction, his stake alone would represent $600 million to $1.2 billion at the higher valuation. However, venture investors and earlier financing rounds typically dilute a founder's share substantially, so the realistic retained stake is almost certainly lower. A conservative working assumption puts his net personal gain from the Nestlé deal in the low-to-mid hundreds of millions, hence the wide range.

For the Long Beach family medicine physician, the picture is completely different. Primary care physicians in California earn a median of roughly $220,000 to $280,000 annually in employed or small-group settings. Over a career, after taxes, living expenses, and standard retirement contributions, a net worth of $1 million to $5 million would be typical for a physician at mid-career, with practice ownership or real estate holdings pushing that higher. There is no public signal that suggests this individual has unusual wealth outside those norms.

Third-party net-worth estimate sites that publish a single number for "Andrew Abraham" without specifying which person they mean should be treated with skepticism. If you want a single-number takeaway for Andrew Maag net worth, most sources are mixing individuals and you should rely on clarified, deal-based estimates instead. These estimates are often summarized in articles about the ms deb antney net worth figure. At least one such site (flagged in our research) does not clearly establish whether the subject is the Orgain founder, the Long Beach physician, or someone else entirely. That kind of name-conflation is exactly the type of red flag to watch for.

Where the estimates come from

For the Orgain founder, the primary evidence trail includes Nestlé Health Science's February 2022 acquisition press release naming Abraham as CEO and Founder, OCBJ's OC50 reporting on Orgain's revenue (~$1B) and valuation ($2B+ at acquisition, $3B+ later), and TheOrg's org chart listing him as both CEO/Founder of Orgain and Managing Partner at Humble Growth (as of July 2022). None of these are personal financial disclosures, but they establish the scale of the business he built and partially owns.

No primary-source personal financial disclosure, tax filing, court-ordered asset schedule, or verified ownership percentage for Andrew Abraham personally has been located in publicly available records. That is normal for a private-company founder; Orgain is not publicly traded, so there are no SEC filings, proxy statements, or Form 4 filings that would reveal exact stake sizes or personal compensation. All net-worth figures for this individual, including the range on this page, are estimates derived from transaction data and reasonable assumptions about founder equity.

What actually drives Andrew Abraham's wealth

Orgain equity and the Nestlé transaction

This is by far the largest wealth driver. Orgain was founded by Abraham after he survived cancer and found commercial nutrition products inadequate during recovery. He built it into a roughly $1 billion revenue brand before Nestlé Health Science paid for a controlling 51% stake at a valuation that exceeded $2 billion. The retained 49% minority interest, split across Abraham and any co-investors or employee equity holders, remains valuable. If valuations held or grew to $3 billion as reported, that minority block is worth roughly $1.5 billion in aggregate, with Abraham's personal share depending on his exact retained percentage.

Ongoing executive compensation

Abraham has continued as CEO of Orgain post-acquisition. CEOs of private companies with $1B+ revenue typically earn base compensation in the $500,000 to $2 million range, though private company CEO pay is not disclosed. This contributes incrementally to net worth but is small relative to the equity position.

Humble Growth and investment activities

TheOrg lists Abraham as Managing Partner at Humble Growth as of July 2022, suggesting venture or growth-equity investment activity alongside his Orgain role. The financial scale of this is unknown from public records, but it signals that Abraham is deploying capital rather than holding only a single asset.

Clinical practice income (historical, minimal)

Abraham left his medical career to focus on Orgain, per both the Orgain origin story and OCBJ's profile. His physician income is therefore historical and not a current wealth driver. This is a meaningful distinction from peers like Anthony Youn, MD or Eric George, MD, whose ongoing clinical practices (plastic and reconstructive surgery, respectively) represent active, high-income revenue streams alongside any media or business activity.

How this estimate is calculated

The methodology here follows a business-equity approach rather than a salary-accumulation approach, since the Orgain stake dominates any reasonable calculation. Here is the logic chain:

1. Establish transaction valuation: Nestlé acquired 51% of Orgain in February 2022. Press reporting places the implied total company valuation at $2 billion or higher at the time of closing, rising to $3 billion+ in later reports.
2. Estimate minority stake value: The remaining 49% is worth roughly $980 million at a $2B valuation or $1.47 billion at a $3B valuation. This is the total minority pool, not Abraham's personal share alone.
3. Adjust for dilution and co-investors: Venture-backed and growth-equity-backed companies typically dilute founder ownership through multiple rounds. Without knowing Abraham's exact retained percentage, a conservative assumption is that founders in similar situations hold 15 to 35 percent of the total company at exit. At $2B valuation and 20% personal ownership, that is $400 million gross.
4. Subtract estimated taxes and liabilities: A liquidity event of this scale in California triggers federal and state capital gains tax. Combined rates can exceed 35 to 40 percent on long-term gains, bringing a $400M gross figure down to roughly $240M to $260M in after-tax proceeds.
5. Add operating assets: Ongoing CEO compensation, investment portfolio activity through Humble Growth, and any real estate or other holdings add to the base. These are unverified and assumed conservatively.
6. Result: A net worth range of $200M to $600M reflects the spread from conservative to optimistic founder-equity assumptions after tax. The midpoint of roughly $350M to $400M is the most defensible single estimate given available data.

This methodology carries real uncertainty. Key unknowns include the precise equity percentage Abraham held pre-acquisition, whether he received cash vs. rollover equity in the Nestlé deal, the current implied valuation of the retained minority stake, and any personal debt or leveraged positions. All of these can move the number materially.

Net worth over time: what can change the number

The Nestlé acquisition in February 2022 is the single most important event in Abraham's financial timeline, representing the first major documented liquidity signal. Since then, the reported valuation growth from $2B to $3B+ suggests the retained minority stake has appreciated, which would push the net worth estimate upward if and when Abraham realizes additional proceeds. Conversely, if Orgain's revenue growth slows or Nestlé writes down the asset, the unrealized minority value could decline.

His role at Humble Growth as of mid-2022 is a newer data point suggesting active capital deployment. Any successful portfolio exits from that vehicle would add to net worth, while early-stage losses could offset it. Future signals to watch include any Nestlé financial disclosures that reference Orgain segment performance, new Orgain product or distribution announcements that imply revenue trajectory, and any California business entity filings or property records in Abraham's name.

How to verify this yourself and what red flags to avoid

Steps for independent verification

1. Confirm identity first: Search the NPI registry at nppes.cms.hhs.gov. The Long Beach family medicine physician has NPI 1740526482. If a source is discussing Orgain, that is a different individual and no NPI-based financial verification applies.
2. Check California Secretary of State records: Search for Orgain Inc. and related entities to identify registered officers and any ownership disclosures. California business entity filings often list officers and registered agents.
3. Search county property records: Los Angeles County and Orange County assessor databases are publicly searchable and can reveal real estate holdings, which are a common indicator of high-net-worth individuals.
4. Look for court records: Asset disclosures sometimes appear in divorce, bankruptcy, or civil litigation filings. A targeted PACER search for Andrew Abraham in California federal courts can surface these if they exist.
5. Review Nestlé Health Science press materials: Nestlé is publicly traded (SIX: NESN), so its press releases and annual reports referencing the Orgain acquisition are reliable, verifiable primary sources for transaction context.
6. Cross-reference OCBJ's OC50 list: The Orange County Business Journal publishes annual profiles of top Orange County executives and business leaders. The 2025 edition includes Abraham and is a credible secondary source.

Red flags that signal an unreliable estimate

• A site that lists an "Andrew Abraham net worth" without specifying Orgain, Long Beach, or any other identifying detail is almost certainly conflating multiple people or fabricating a figure.
• Round numbers presented with false precision (e.g., "$450,000,000 exactly") without a methodology note should be ignored.
• Sites that recycle the same figure year over year without adjusting for known events like the Nestlé deal are not tracking real data.
• Any source that describes Andrew Abraham, MD as an actively practicing physician and also attributes Orgain founder wealth to him is confusing two different people or getting the timeline wrong. Abraham left practice to build Orgain.
• Name-conflation with the Phoenix lobbyist, the Montana business owner, or the bankruptcy court filing reference is a signal that a source is scraping public records indiscriminately rather than researching the specific individual.

Quick comparison: Orgain founder vs. practicing physician net worth profiles

If you are comparing physician-entrepreneur net worth profiles, the Orgain founder sits in a much higher tier than typical practicing physicians, even high-earning specialists. If you specifically mean Nate Gross, MD, his net worth discussion usually depends on where the figures come from and which sources are credible. For context, physician-focused profiles like those for Anthony Youn, MD or Eric George, MD reflect wealth built through a combination of active clinical practice, media presence, and potentially practice equity, but rarely approach the scale that a successful consumer brand exit can generate. Some readers also search for Anthony William Medical Medium net worth, but results can mix up different people or roles, so it is important to verify the exact subject before trusting any number. Eric George, MD net worth estimates should be treated as unreliable unless the specific physician, location, and evidence for income or ownership are clearly identified. Profiles tied to Anthony Youn, MD can differ greatly depending on whether the source is discussing a specific physician’s practice, media activity, or other assets. The Orgain story is more comparable to a tech founder outcome than a traditional physician wealth trajectory. That same Orgain founder profile is often tied to discussions of Abner Mares net worth online.